论文部分内容阅读
癌症的早期发现对于治疗效果意义重大,但就“癌中之王”肝癌来说,早期诊断却一直是全球专家面临的难题。本月上旬,国际学术杂志《自然—材料》上发表的一篇文章引起了国内外关注——中山大学肿瘤防治中心主任、医院院长徐瑞华与美国加州大学圣地亚哥分校教授张康一同带领的中美科学家团队研究发现,通过检测少量血液中循环肿瘤DNA(ctDNA)特定位点甲基化水平,可对肝癌进行早期诊断和疗效以及预后预测。
The early detection of cancer is of great significance to the treatment effect, but in the case of “cancer of the king” "liver cancer, early diagnosis has always been a challenge for global experts. Earlier this month, an article published in the journal Nature - Materia Medica drew the attention of both at home and abroad - Xu Ruihua, director of the Sun Yat-sen University Cancer Center, and Zhang Kang, a professor at the University of California San Diego, The team of scientists found that liver cancer can be diagnosed and treated early and prognosis predicted by detecting the level of methylation at a specific site of circulating tumor DNA (ctDNA) in a small amount of blood.